ZA969759B - Tumour vaccines and processes for preparing them. - Google Patents

Tumour vaccines and processes for preparing them.

Info

Publication number
ZA969759B
ZA969759B ZA9609759A ZA969759A ZA969759B ZA 969759 B ZA969759 B ZA 969759B ZA 9609759 A ZA9609759 A ZA 9609759A ZA 969759 A ZA969759 A ZA 969759A ZA 969759 B ZA969759 B ZA 969759B
Authority
ZA
South Africa
Prior art keywords
preparing
processes
tumour vaccines
tumour
vaccines
Prior art date
Application number
ZA9609759A
Inventor
Walter Schmidt
Max Birnstiel
Tamas Schweighoffer
Peter Steinlein
Michael Buschle
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA969759B publication Critical patent/ZA969759B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA9609759A 1995-11-23 1996-11-21 Tumour vaccines and processes for preparing them. ZA969759B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19543649A DE19543649C2 (en) 1995-11-23 1995-11-23 Tumor vaccine and process for its manufacture

Publications (1)

Publication Number Publication Date
ZA969759B true ZA969759B (en) 1997-08-14

Family

ID=7778201

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9609759A ZA969759B (en) 1995-11-23 1996-11-21 Tumour vaccines and processes for preparing them.

Country Status (3)

Country Link
DE (1) DE19543649C2 (en)
UA (1) UA66753C2 (en)
ZA (1) ZA969759B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571711A (en) * 1993-06-17 1996-11-05 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors

Also Published As

Publication number Publication date
DE19543649A1 (en) 1997-05-28
DE19543649C2 (en) 1998-01-29
UA66753C2 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
GB9513261D0 (en) Vaccines
HUP9800208A3 (en) Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them
HK1002055A1 (en) Polyepitope vaccines.
GR970300037T1 (en) Phenol-derivatives having pharmaceutical activity and process for preparing the same
HU9502720D0 (en) Process for preparing cancer vaccines
AU7694796A (en) Tumour vaccine and processes for preparing it
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
EP0669363A3 (en) Process for preparing polyorganosilane.
EP0622369A3 (en) 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof.
ZA9610102B (en) Salmonella vaccines.
ZA966603B (en) Therapeutic method.
EP0621866A4 (en) Process for preparing 3-acylestratrienes and acylbenzenes.
ZA982449B (en) Process for preparing 1-Alkyl-4-(2-chloro-3-alkoxy-4-alkylsulfonylbenzoyl)-5-hydroxypyrazole and related compounds.
ZA9610053B (en) Process for preparing dioxoazabicyclohexanes.
ZA969759B (en) Tumour vaccines and processes for preparing them.
EP0775705A3 (en) Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein
AU4715196A (en) Desaminononapeptides, process for preparing the same and their use for preparing elcatonin
EP0681480A4 (en) Recognin vaccines.
ZA939564B (en) Vaccines.
GR930300114T1 (en) Esters, process for their preparation and use.
EP0754665A3 (en) 3-substituted-alpha,beta-dibromoethylbenzene and process for preparing the same
NZ332994A (en) Iron-casein complex and process for preparing the same
ZA967198B (en) Vaccines.
EP1013277A4 (en) Freeze-dried preparations and process for producing the same
HUP9801594A3 (en) Novel seco-azalides and process for preparing them